Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis.
Iwasaki T, Watanabe R, Ito H, Fujii T, Okuma K, Oku T, Hirayama Y, Ohmura K, Murata K, Murakami K, Yoshitomi H, Tanaka M, Matsuda S, Matsuda F, Morinobu A, Hashimoto M.
Iwasaki T, et al. Among authors: yoshitomi h.
Front Immunol. 2022 Jun 6;13:901437. doi: 10.3389/fimmu.2022.901437. eCollection 2022.
Front Immunol. 2022.
PMID: 35734167
Free PMC article.